BMY vs ECL · P/E 17, rev $48.19B vs P/E 35, rev $4.01B
Bristol-Myers Squibb Company (BMY) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BMY and ECL stock pages for the full models.
Not investment advice.